The Cost of Missed Diagnoses in SNFs
Missed diagnoses in SNFs carry significant financial implications. These also negatively impact patient well-being.
Key Facts
- Missed diagnoses lead to increased costs and poor patient outcomes.
- AI can improve diagnostic accuracy and reduce errors.
- Early and accurate diagnoses improve care and reduce financial burden.
Missed diagnoses in SNFs carry significant financial implications. These also negatively impact patient well-being. GIA® screens using digitalhumanOS™ provide a solution. By leveraging AI, facilities can enhance diagnostic accuracy, reduce the risk of errors, and ultimately improve patient outcomes while minimizing financial losses.
Improved Accuracy
AI enhances diagnostic accuracy, reducing the risk of errors.
Reduced Costs
Accurate diagnoses minimize unnecessary treatments and hospital readmissions.
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.
Better Outcomes
Timely and accurate diagnoses lead to improved patient outcomes.
Financial Benefits
Minimize financial losses associated with missed diagnoses proactively.
Conclusion
GIA® screens using digitalhumanOS™ offer a cost-effective solution. Improve diagnostic accuracy, reduce financial losses, and enhance patient care. Invest in the future of SNF care. Learn how automated screening catches what manual workflows miss.
Sources & References
- 94% of LTC facilities report understaffing. 47% at financial closure risk. Nurses spend 28.8% of time on documentation. Scienza Health proof point, sourced from internal operational data.
- Scienza Health internal validation: 12.3M longitudinal PAC/LTC patient records, 27B clinical events, 46 conditions screened.
- Wyoming Health Innovation Living Lab Case Study. 2024. Real-world validation of voice biomarker technology.
David Kaiser is the Founder and CEO of Scienza Health. He leads the development of GIA® and digitalhumanOS™, a clinically validated speech biomarker platform that screens for 46 cognitive and neurological conditions in under 5 minutes.
This content is intended for informational purposes and does not constitute medical advice. Editorially reviewed by David Kaiser, CEO of Scienza Health, for accuracy in post-acute care operations.
Frequently Asked Questions
How does AI improve diagnosis?
By analyzing data and identifying potential issues.
What types of diagnoses can it help with?
A wide range, including infections and cardiovascular conditions.
What is the ROI?
Reduced costs and improved patient outcomes.
The Clinical Signal
Hear the latest episode on clinical AI screening in post-acute care.